Tract

A campaign to improve awareness and understanding of urinary tract infections (UTIs) has been launched by the NHS. The campaign, being run by NHS England and UK Health Security Agency (UKHSA), is designed to remind people, especially those…

A team of researchers from the University of Maryland School of Maryland's (UMSOM) Institute of Human Virology (IHV), a Center of Excellence of the Global Virus Network (GVN), published new findings that emphasize the crucial role of the…

Drinking cranberry juice has long been a mythical prevention strategy for women who develop a urinary tract infection -- and new medical evidence shows consuming cranberry products is an effective way to prevent a UTI before it gets…

<!-- Name:DistributionId Value:8809633 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

Merck's (MRK) KEYTRUDA plus chemo 'significantly' improves overall survival in binary tract cancer Merck (MRK) announced results from the Phase 3 KEYNOTE-966 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination…

Only humans have the ability to use speech. Remarkably, this communication is understandable across accent, social background, and anatomy despite a wide variety of ways to produce the necessary sounds. In JASA, published on behalf of the…

Engineers at MIT and Caltech have demonstrated an ingestible sensor whose location can be monitored as it moves through the digestive tract, an advance that could help doctors more easily diagnose gastrointestinal motility disorders such as…

Elana Gotkine MONDAY, Jan. 23, 2023 (HealthDay News) -- For patients with biliary tract cancer (BTC), no significant improvement is observed in overall survival with the addition of albumin-bound…

Lori Solomon MONDAY, Jan. 23, 2023 (HealthDay News) -- The NoMicro classifier appears accurate for evaluating urine cultures in cases of suspected urinary tract infection in the primary care setting…

Compass to Host Investor Event on Monday, January 23rd at 8:30am ET CTX-009 in combination with paclitaxel demonstrated a 37.5% overall response rate (ORR) in 24 patients with BTC treated in the second- and third- line settings; at least…